Huntington Disease - 29 Studies Found

Completed : Neuroprotection by Cannabinoids in Huntington's Disease
: Huntington's Disease
: 2011-12-29
:
  • Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

Completed : A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease
: Huntington Disease
: 2008-07-24
:
  • Drug: ACR16 10 mg ACR16 capsul
Completed : Pilot Study of Minocycline in Huntington's Disease
: Huntington Disease
: 2006-01-12
:
  • Drug: minocycline Minocycline:
Completed : A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington's Disease
: Huntington's Disease
: 2008-04-22
:
  • Drug: ACR16 45 mg capsules Cap
Active, not recruiting : Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
: Huntington Disease
: 2011-02-28
: Drug: pridopidine 45mg bid
Active, not recruiting : Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
: Huntington Disease
: 2003-01-08
Completed : Creatine Therapy for Huntington's Disease
: Huntington's Disease
: 2001-11-15
: Drug: Creatine
Completed : A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
: Huntington's Disease
: 2007-07-03
:
  • Other: Placebo Placebo TID x 9
Completed : Bioavailability of Ubiquinol in Huntington Disease
: Huntington Disease
: 2009-09-17
: Dietary Supplement: ubiquinol up to 600 mg per day, oral capsules for 8 weeks
Completed : Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
: Huntington Disease
: 2012-03-11
Next >>>